Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL

  • Gannie Tzoneva
  • , Arianne Perez-Garcia
  • , Zachary Carpenter
  • , Hossein Khiabanian
  • , Valeria Tosello
  • , Maddalena Allegretta
  • , Elisabeth Paietta
  • , Janis Racevskis
  • , Jacob M. Rowe
  • , Martin S. Tallman
  • , Maddalena Paganin
  • , Giuseppe Basso
  • , Jana Hof
  • , Renate Kirschner-Schwabe
  • , Teresa Palomero
  • , Raul Rabadan
  • , Adolfo Ferrando

Research output: Contribution to journalArticlepeer-review

307 Scopus citations

Fingerprint

Dive into the research topics of 'Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry